AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABCL AbCellera Biologics

Trading 10-09 10:44:52 EDT

12.33

+0.31

+2.58%

High12.60	Low11.93	Vol1.28M
Open12.03	D1 Closing12.02	Amplitude5.57%
Mkt Cap3.99B	Tradable Cap2.72B	Total Shares324.00M
T/O15.83M	T/O Rate0.58%	Tradable Shares221.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABCL","market":"US","secType":"STK","nameCN":"AbCellera Biologics","latestPrice":12.33,"timestamp":1791557091555,"preClose":12.02,"halted":0,"volume":1283923,"delay":0,"changeRate":0.025790349417637314,"floatShares":221000000,"shares":324000000,"eps":-0.545545,"marketStatus":"Trading","change":0.31,"latestTime":"10-09 10:44:52 EDT","open":12.03,"high":12.6,"low":11.93,"amount":15832129.622495499,"amplitude":0.05574,"askPrice":12.34,"askSize":130,"bidPrice":12.33,"bidSize":447,"shortable":3,"etf":0,"ttmEps":-0.545545,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1607662800000,"exchange":"NASDAQ","adjPreClose":12.02,"preHourTrading":{"tag":"盘前","latestPrice":12.25,"preClose":12.02,"latestTime":"09:29 EDT","volume":17514,"amount":213901.161642,"timestamp":1791552592855,"change":0.23,"changeRate":0.019135,"amplitude":0.039101},"postHourTrading":{"tag":"盘后","latestPrice":12.17,"preClose":12.02,"latestTime":"19:59 EDT","volume":98676,"amount":1192084.8248,"timestamp":1791503972762,"change":0.15,"changeRate":0.012479,"amplitude":0.013311},"volumeRatio":1.073127,"impliedVol":0.8424,"impliedVolPercentile":0.1713},"requestUrl":"/m/hq/s/ABCL","defaultTab":"news","newsList":[{"id":"2674006810","title":"AbCellera to present Phase 1/2 data for ABCL635 at TMS 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2674006810","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674006810?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:11","pubTimestamp":1791490270,"startTime":"0","endTime":"0","summary":"AbCellera (ABCL) “announced an upcoming poster presentation of Phase 1/2 data on ABCL635 at The Menopause Society’s 2026 Annual Meeting, to be held...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-1-2-data-for-abcl635-at-tms-2026-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-1-2-data-for-abcl635-at-tms-2026-annual-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672644487","title":"Press Release: AbCellera to Report Third Quarter 2026 Financial Results on November 9, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672644487","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672644487?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:14","pubTimestamp":1790885640,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia--(BUSINESS WIRE)--October 01, 2026--AbCellera (Nasdaq: ABCL) will announce its third quarter 2026 financial results on Monday, November 9, 2026, and hold an earnings confer","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","ABCL","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672764995","title":"AbCellera Schedules Quarterly Results Release, Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672764995","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672764995?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:05","pubTimestamp":1790885119,"startTime":"0","endTime":"0","summary":"AbCellera schedules quarterly results release, earnings callAbCellera will release third-quarter 2026 financial results on Nov. 9, 2026.Earnings conference call set for Nov. 9, 2026 at 3:00 p.m. PT, 5","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL7CrkLy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671292244","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2671292244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671292244?lang=en_us&edition=fundamental","pubTime":"2026-09-30 03:05","pubTimestamp":1790708710,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 8,557 calls trading, 3x expected, and implied vol increasing over 1 point to 92.67%...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-7?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-7?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671218947","title":"JPMorgan Initiates AbCellera Biologics at Overweight With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2671218947","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671218947?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:53","pubTimestamp":1790675636,"startTime":"0","endTime":"0","summary":"AbCellera Biologics (ABCL) has an average rating of buy and mean price target of $16.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PGF","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671297157","title":"Abcellera Biologics Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2671297157","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671297157?lang=en_us&edition=fundamental","pubTime":"2026-09-29 17:03","pubTimestamp":1790672608,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nFWN45L0B1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670404312","title":"JonesTrading Sticks to Their Buy Rating for AbCellera Biologics (ABCL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670404312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670404312?lang=en_us&edition=fundamental","pubTime":"2026-09-28 05:55","pubTimestamp":1790546117,"startTime":"0","endTime":"0","summary":"JonesTrading analyst Debanjana Chatterjee reiterated a Buy rating on AbCellera Biologics today and set a price target of $25.00. Chatterjee covers ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-abcellera-biologics-abcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jonestrading-sticks-to-their-buy-rating-for-abcellera-biologics-abcl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669602024","title":"AbCellera Biologics Price Target Announced at $13.00/Share by Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669602024","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669602024?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:12","pubTimestamp":1790251920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABCL/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460679","title":"AbCellera Biologics (ABCL) Receives a Hold from Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460679","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460679?lang=en_us&edition=fundamental","pubTime":"2026-09-24 19:45","pubTimestamp":1790250326,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Andrea Newkirk resumed coverage with a Hold rating on AbCellera Biologics today and set a price target of $13.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-receives-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/abcellera-biologics-abcl-receives-a-hold-from-goldman-sachs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2471134796.USD","IE00B19Z3B42.SGD","LU0210536198.USD","LU0048573561.USD","LU0251131958.USD","LU1868836591.USD","BK4535","LU2471134523.USD","LU0742534661.SGD","LU0868494708.USD","IE0002270589.USD","LU2896262040.SGD","LU2471134952.CNY","LU1894683264.USD","IE0034235188.USD","LU2750360641.GBP","ABCL","GSX","BK4550","BK4516","LU1791807156.HKD","BK4552","LU0868494617.USD","IE0004086264.USD","LU1868837136.USD","LU2237438978.USD","BK4121","LU1144417596.USD","LU1868836757.USD","LU0096364046.USD","LU0251142724.SGD","LU2237443895.HKD","LU2237443382.USD","LU2237443622.USD","LU2237443465.HKD","LU1894683348.USD","BK4504","LU0345770308.USD","BK4585","BK4127","IE00BSNM7G36.USD","LU2471134879.HKD","IE00B19Z3581.USD","IE0004091025.USD","LU2265009873.SGD","LU1668664300.SGD","LU1804176565.USD","BK4588","LU1868837300.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169510","title":"Pharma Sector Doubles Down on AI to Slash Costs, Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169510?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:50","pubTimestamp":1789998651,"startTime":"0","endTime":"0","summary":"FACTBOX-Pharma sector doubles down on AI to slash costs, timelinesSept 21 (Reuters)-Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate research and development,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL4N45D0WW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NULC","NVDY","ILDR","NVDQ","NVDS","TEK","TMED","NVII","TTXU","RNAM","INCY","ARTY","NVDD","TTEQ","VOX","KVUE","03165","ABCL","GOOGL","HEAL","LH","NVDU","ROM","KD","OZEM","TMO","NVDL","VHT","NVDX","NVD","JGRO","PAWZ","TRUH","ILMN","NVDA","FTEC","MSFT","TYLG","NVDG","VT","ANV","VGT","PFE","AZN.UK","MRK","RSPS","BMED","IQV","ABBV","BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668966649","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2668966649","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668966649?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:45","pubTimestamp":1789659911,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 9,247 calls trading, 4x expected, and implied vol increasing over 10 points to 88.1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-6?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668337689","title":"AbCellera to present Phase 2 Data for ABCL635 at IMS Congress on Menopause","url":"https://stock-news.laohu8.com/highlight/detail?id=2668337689","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668337689?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:10","pubTimestamp":1789589409,"startTime":"0","endTime":"0","summary":"AbCellera (ABCL) “announced an upcoming oral presentation of Phase 2 data on ABCL635 at the International Menopause Society 20th World Congress on ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-2-data-for-abcl635-at-ims-congress-on-menopause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-to-present-phase-2-data-for-abcl635-at-ims-congress-on-menopause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668331669","title":"AbCellera to Present Phase 2 Abcl635 Data for Menopause Hot Flashes at IMS World Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2668331669","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668331669?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:06","pubTimestamp":1789589166,"startTime":"0","endTime":"0","summary":"AbCellera to present Phase 2 ABCL635 data for menopause hot flashes at IMS World Congress 2026Abcellera flagged upcoming Phase 2 data for ABCL635, a non-hormonal antibody for menopausal hot flashes, a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL4c4PXN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4535","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667723621","title":"AbCellera Biologics call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2667723621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667723621?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:10","pubTimestamp":1789499424,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in AbCellera (ABCL) Biologics with 5,617 calls trading, 1.1x expected, and implied vol increasing over 1 point to 81.3...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-biologics-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664849535","title":"AbCellera to Present at Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664849535","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664849535?lang=en_us&edition=fundamental","pubTime":"2026-09-03 04:06","pubTimestamp":1788379602,"startTime":"0","endTime":"0","summary":"AbCellera to present at Cantor Global Healthcare ConferenceAbCellera will present at the Cantor Global Healthcare Conference on Sept. 9, 2026.Disclaimer:This news brief was created by Public Technolog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDLGl90Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1139190275","title":"Movement Alert｜AbCellera Biologics Falls 8.02% in Regular Trading, Life Sciences Sector Broadly Under Pressure Post Dilutive Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=1139190275","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139190275?lang=en_us&edition=fundamental","pubTime":"2026-08-29 00:30","pubTimestamp":1787934627,"startTime":"0","endTime":"0","summary":"On August 29, AbCellera Biologics fell 8.02% in regular trading, trading at $11.395/share, with turnover of $33.19 million.The decline came amid broad-based weakness across the Life Sciences Tools &...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"AbCellera Falls After $200M Dilutive Offering","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754748","title":"U.S. Small Caps Finish Mixed as AbCellera Biologics Leads, Bath & Body Works Lags","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754748","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754748?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:21","pubTimestamp":1787689260,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of small-cap companies were mixed Tuesday, as the Russell 2000 Index added 0.5%, and the S&P Small Cap 600 Index was unchanged.Among companies with a market value of $1 billion to $6.7 billion, AbCellera Biologics Inc. was the best performer during the session, surging 18%, followed by Inhibrx Biosciences Inc., which surged 17%. Generate Biomedicines Inc. shares surged 15%, Resolute Holdings Management surged 12%, and shares of Nayax Ltd. surged 12%.Bath & Body Works Inc. was the biggest laggard, dropping 8.3%, followed by shares of BETA Technologies Inc. Cl A, which dropped 7.3%. Shares of Lyntris Inc. dropped 6.8%, Evolution Metals & Technologies Corp. shares plunged 6.4%, and EverCommerce Inc. tumbled 6.2%.Major stock indexes in the U.S. closed up Tuesday with the Nasdaq Composite Index gaining 0.7%. Meanwhile, the S&P 500 Index increased 0.3%, and the Dow Jones Industrial Average added 0.3%.Data source: Dow ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4121","ABCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662569607","title":"AbCellera rises 17.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662569607","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662569607?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:06","pubTimestamp":1787673965,"startTime":"0","endTime":"0","summary":"AbCellera (ABCL) is up 17.0%, or $1.80 to $12.41. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/abcellera-rises-17-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/abcellera-rises-17-0-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABCL","BK4535","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662200285","title":"Major Insider Move Signals Growing Confidence in AbCellera Biologics","url":"https://stock-news.laohu8.com/highlight/detail?id=2662200285","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662200285?lang=en_us&edition=fundamental","pubTime":"2026-08-25 10:08","pubTimestamp":1787623726,"startTime":"0","endTime":"0","summary":"New insider activity at AbCellera Biologics ( ($ABCL) ) has taken place on August 24, 2026. Director Michael R. Hayden has demonstrated confidence ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-insider-move-signals-growing-confidence-in-abcellera-biologics-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","ABCL","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662527209","title":"Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2662527209","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662527209?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:22","pubTimestamp":1787606551,"startTime":"0","endTime":"0","summary":"Abcellera director Michael R. Hayden reports $570,442 common share purchaseAbCellera Biologics director Hayden Michael R Hayden reported a purchase of 53,613 common shares at USD 10.64.Indirect holdin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLZ9w7w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Abcellera Director Michael R. Hayden Reports $570,442 Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABCL","BK4121","BK4535"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abcellera.com","stockEarnings":[{"period":"1week","weight":-0.1359},{"period":"1month","weight":0.0507},{"period":"3month","weight":0.7676},{"period":"6month","weight":2.3955},{"period":"1year","weight":0.9481},{"period":"ytd","weight":2.5146}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company had discovery programs that are either completed, in progress, or under contract with partners. It has a research collaboration and license agreement with Eli Lilly and Company; and a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.002724},{"month":2,"riseRate":0,"avgChangeRate":-0.119779},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.059327},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.055905},{"month":5,"riseRate":0.666667,"avgChangeRate":0.054331},{"month":6,"riseRate":0.5,"avgChangeRate":0.144975},{"month":7,"riseRate":0.5,"avgChangeRate":-0.006532},{"month":8,"riseRate":0.5,"avgChangeRate":0.100971},{"month":9,"riseRate":0.666667,"avgChangeRate":0.075704},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024867},{"month":11,"riseRate":0.6,"avgChangeRate":-0.007841},{"month":12,"riseRate":0.2,"avgChangeRate":-0.030878}],"exchange":"NASDAQ","name":"AbCellera Biologics","nameEN":"AbCellera Biologics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AbCellera Biologics,ABCL,AbCellera Biologics股票,AbCellera Biologics股票老虎,AbCellera Biologics股票老虎国际,AbCellera Biologics行情,AbCellera Biologics股票行情,AbCellera Biologics股价,AbCellera Biologics股市,AbCellera Biologics股票价格,AbCellera Biologics股票交易,AbCellera Biologics股票购买,AbCellera Biologics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AbCellera Biologics(ABCL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AbCellera Biologics(ABCL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}